Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Pharmacotherapy|July 26, 2006
Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational studyCarla M Peterman, Daniel M Kolansky, Sarah A Spinler
Pharmacotherapy|April 10, 2002
Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresisMichelle L Willey, Simon de Denus, Sarah A Spinler
Journal of the American Pharmacists Association : Japha|May 10, 2016
What's next for dyslipidemia management? The 2013 ACC/AHA Guidelines, the NLA recommendations, and beyondLaura H Waite, Yvonne L Phan, Sarah A Spinler
Pharmacotherapy|October 27, 2006
Role of P-glycoprotein in statin drug interactionsCarol W Holtzman, Barbara S Wiggins, Sarah A Spinler
Pharmacotherapy|August 16, 2014
Cangrelor: a novel intravenous antiplatelet agent with a questionable futureLaura H Waite, Yvonne L Phan, Sarah A Spinler
Journal of the American Pharmacists Association : Japha|April 21, 2004
Secondary prevention of acute coronary syndromesJanet H Dailey, Mark J Cziraky, Sarah A Spinler
Clinical Therapeutics|June 4, 2011
Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrelMichelle T Martin, Sarah A Spinler, Edith A Nutescu
Pharmacotherapy|January 5, 2005
History of depression as a predictor of adverse outcomes in patients hospitalized for decompensated heart failureSimon de Denus, Sarah A Spinler, Mariell Jessup, et al.
Pageof 8